Bromocriptine Mesylate

CAS 22260-51-1 9 FDA-DMF suppliersSmall Molecule

Overview

Bromocriptine Mesylate is an ergot derivative medication primarily used in the treatment of hyperprolactinemia, Parkinson's disease, and Type 2 diabetes. It acts as a dopamine D2 receptor agonist to inhibit the secretion of prolactin from the pituitary gland.

API suppliers (8)

Suppliers of Bromocriptine Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV1 active DMF
  • CURIA ITALY SRL1 active DMF
  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • LABOCHIM
  • CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
  • GALENA AS
  • CHEMAPOL LTD

Therapeutic areas

EndocrinologyNeurologyReproductive Health

Related APIs

Testosterone
18 suppliers
Cabergoline
10 suppliers
Testosterone Enanthate
9 suppliers
Sitagliptin
50 suppliers
Aripiprazole
45 suppliers
Empagliflozin
42 suppliers
Pregabalin
40 suppliers
Levetiracetam
37 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo